Streptococcal Pneumonia - Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Streptococcal Pneumonia - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Streptococcal Pneumonia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Streptococcal Pneumonia) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Streptococcal Pneumonia Overview
  3. Therapeutics Development
  4. Pipeline Products for Streptococcal Pneumonia - Overview
  5. Pipeline Products for Streptococcal Pneumonia - Comparative Analysis
  6. Streptococcal Pneumonia - Therapeutics under Development by Companies
  7. Streptococcal Pneumonia - Therapeutics under Investigation by Universities/Institutes
  8. Streptococcal Pneumonia Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Streptococcal Pneumonia - Products under Development by Companies
  13. Streptococcal Pneumonia - Products under Investigation by Universities/Institutes
  14. Streptococcal Pneumonia - Companies Involved in Therapeutics Development
  • Abera Bioscience AB
  • Actelion Ltd
  • Alvogen Korea Co., Ltd.
  • Arsanis Biosciences GmbH
  • AstraZeneca Plc
  • Beijing Minhai Biotechnology Co., Ltd
  • ContraFect Corporation
  • Daiichi Sankyo Company, Limited
  • Eurocine Vaccines AB
  • FluGen, Inc.
  • GlaxoSmithKline Plc
  • ImmunoBiology Limited
  • Lascco SA
  • Liquidia Technologies, Inc.
  • Merck & Co., Inc.
  • Mucosis B.V.
  • Panacea Biotec Limited
  • Prometheon Pharma, LLC
  • Sanofi Pasteur SA
  • Serum Institute of India Limited
  • SK Chemicals Co., Ltd.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Valneva SE
  • Vaxxilon AG
  • Virometix AG
  • Walvax Biotechnology Co., Ltd.
  • Wellstat Vaccines, LLC
  • Wockhardt Limited

For more information visit http://www.researchandmarkets.com/research/pbhlwm/streptococcal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory Drugs, Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory Drugs, Infectious Diseases Drugs